Skip to content
  • Biomarkers & Diagnostics
    • pUB Biomarker Overview
    • Diagnostic Services
    • Personalized Medicine
  • Our Science
    • Mitochondrial Root Cause
    • Mitophagy & Mitobiogenesis
    • Ubiquitin Proteasome System (UPS)
    • Therapeutic Targets
  • Partnering
    • Pharma & Biotech Collaborations
    • Tools & Probes
    • Academic & Foundation Partnerships
  • Resources
    • Key Publications
    • News & Articles
    • Insights
    • FAQ
  • Biomarkers & Diagnostics
    • pUB Biomarker Overview
    • Diagnostic Services
    • Personalized Medicine
  • Our Science
    • Mitochondrial Root Cause
    • Mitophagy & Mitobiogenesis
    • Ubiquitin Proteasome System (UPS)
    • Therapeutic Targets
  • Partnering
    • Pharma & Biotech Collaborations
    • Tools & Probes
    • Academic & Foundation Partnerships
  • Resources
    • Key Publications
    • News & Articles
    • Insights
    • FAQ
Partner With Us

Research Disclaimer

MyToHealth LLC is a specialized biotechnology company developing novel blood-based biomarkers and therapeutic discovery platforms for age-related neurodegenerative diseases.

Biomarkers & Science

  • pUB Biomarker Platform
  • Blood-Based Diagnostics
  • Mitophagy & Biogenesis
  • Ubiquitin Proteasome System
  • Research Publications

Partnerships

  • Pharma & Biotech Collaboration
  • Research Foundations (MJFF)
  • Diagnostic Laboratories
  • Tools & Probes (MTA)
  • Technology Sharing

Corporate Headquarters

MyToHealth LLC
Great Valley Corporate Center
271 Great Valley Parkway, Suite 400
Malvern, PA 19355, USA

Phone: (610) 644-6974
Inquiries: bd@mytohealth.net
  • 2026 MyToHealth LLC. All rights reserved.
  • Privacy Policy
  • Terms of Use
  • Research Disclaimer
R&D Facilities: Malvern, PA (Philadelphia Suburb)